| 1. |
中华医学会眼科学会眼底病学组. 中国早产儿视网膜病变筛查指南(2014年)[J]. 中华眼科杂志, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.Chinese Medical Association Ophthalmology Group. Screening guide for retinopathy of premature infants in China[J]. Chin J Ophthalmol, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.
|
| 2. |
易佐慧子, 陈长征. 玻璃体腔注射抗血管内皮生长因子药物治疗早产儿视网膜病变的研究现状[J]. 中华眼底病杂志, 2014, 30(1): 103-106. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.030.Yi ZHZ, Chen CZ. Current status of intravitreal injection of anti-vascular endothelial growth factor in the treatment of retinopathy in premature infants[J]. Chin J Ocul Fundus Dis, 2014, 30(1): 103-106. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.030.
|
| 3. |
Harper CA 3rd, Wright LM, Young RC, et al. Fluorescein angiographic evaluation of peripheral retinal vasculature after primary intravitreal ranibizumab for retinopathy of prematurity[J]. Retina, 2018, 39(4): 700-705. DOI: 10.1097/IAE.0000000000001996.
|
| 4. |
Lepore D, Quinn GE, Molle F, et al. Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings[J]. Ophthalmology, 2018, 125(2): 218-226. DOI: 10.1016/j.ophtha.2017.08.005.
|
| 5. |
Lepore D, Quinn GE, Molle F, et al. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings[J]. Ophthalmology, 2014, 121(11): 2212-2219. DOI: 10.1016/j.ophtha.2014.05.015.
|
| 6. |
Fung TH, Muqit MM, Mordant DJ, et al. Noncontact high-resolution ultra-wide-field oral fluorescein angiography in premature infants with retinopathy of prematurity[J]. JAMA Ophthalmol, 2014, 132(1): 108-110. DOI: 10.1001/jamaophthalmol.2013.6102.
|
| 7. |
陈长征, 许阿敏. 提升超广角荧光素眼底血管造影技术应用水平, 深化周边眼底特征观察及临床意义研究[J]. 中华眼底病杂志, 2017, 33(1): 7-9. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.003.Chen CZ, Xu AM. Improve our understanding of ocular fundus diseases with ultra-wide-field fluorescein angiography[J]. Chin J Ocul Fundus Dis, 2017, 33(1): 7-9. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.003.
|
| 8. |
Calvo CM, Hartnett ME. The utility of ultra-widefield fluorescein angiography in pediatric retinal diseases[J/OL]. Int J Retina Vitreous, 2018, 4: 21[2018-06-05]. https://journalretinavitreous.biomedcentral.com/articles/10.1186/s40942-018-0122-2. DOI: 10.1186/s40942-018-0122-2.
|
| 9. |
Vogel RN, Strampe M, Fagbemi OE, et al. Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity[J]. Ophthalmology, 2018, 125(3): 444-452. DOI: 10.1016/j.ophtha.2017.09.020.
|
| 10. |
Wu WC, Lin RI, Shih CP, et al. Visual acuity, optical components, and mac ular abnormalities in patients with a history of retinopathy of prematurity[J]. Ophthalmology, 2012, 119(9): 1907-1916. DOI: 10.1016/j.ophtha.2012.02.040.
|
| 11. |
Maldonado RS, O'Connell RV, Sarin N, et al. Dynamics of human foveal dev elopment after premature birth[J]. Ophthalmology, 2011, 118(12): 2315-2325. DOI: 10.1016/j.ophtha.2011.05.028.
|
